Product Reports Resources Pricing Login Book a demo

Rivia

Biotech & Life Sciences · Zurich, Switzerland · Founded 2022

Data Analytics Platform for Clinical Trials MoreLess

Rivia operates within the health and wellness technology sector, offering a platform designed to streamline the patient experience for health and aesthetic procedures. The company was founded in 2022 by Matheus Goyas, André Parente, and Guilherme Fluhr. Goyas, serving as CEO, brings prior entrepreneurial experience from his time at Apptite, a food delivery startup he founded and later sold. This background in creating user-centric technology platforms informs Rivia's approach to the healthcare market. The company targets clinics and hospitals, providing them with a digital infrastructure to manage the entire patient journey, from initial contact to post-procedure follow-up.

The business functions on a B2B2C model, equipping healthcare providers with tools to enhance patient engagement and operational efficiency. For patients, Rivia offers a centralized platform where they can discover and schedule procedures, access financing options, and manage their treatment plans. This approach aims to simplify what can be a fragmented and complex process. For clinics, the platform serves as a management system to handle scheduling, patient communication, and financial transactions. Rivia's revenue is generated through a combination of monthly subscription fees paid by the clinics for using the platform and a commission on the financial transactions processed through their system, including any financing arranged for patients.

A significant milestone for the company was securing a $15 million Series A funding round in April 2023, co-led by Valor Capital Group and Base10 Partners. This capital infusion was earmarked for product development, expanding the team, and increasing the network of partner clinics. The platform's core service is to digitize and integrate the various steps of elective medical treatments. It provides a marketplace for consumers to find and compare providers for aesthetic and other wellness procedures. Its integrated financing solution is a key feature, allowing patients to apply for and receive credit to cover the costs of their treatments directly within the platform, thereby increasing accessibility to these services. By consolidating these functions, Rivia aims to improve conversion rates for its partner clinics and offer a more cohesive and transparent experience for patients.

Keywords: healthtech, patient journey, medical financing, clinic management software, aesthetic procedures, B2B2C platform, SaaS, marketplace, patient engagement, wellness technology

Company overview

Rivia company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2022
Headquarters
Zurich, Switzerland
Employees
29
Open positions
None listed
Dealroom signal
89.5
client focusb2bsub industryPharmaceuticalsub industryHealth Platformbusiness modelSaaSindustryHealthsectorData AnalyticssectorBiotechnologysectorClinicalsectorClinical TrialssectorAI Drug DiscoverysectorTechbiosectorTechbio Drug DiscoverysectorDigital PharmasectorDT and LS

Valuation & funding

Rivia funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Mar 2026 $14M $57M Speedinvest · Defiant · Amino Collective · Earlybird Venture Capital
SEEDEquity / VC Jun 2024 $3.3M $13M Speedinvest · Nina Capital · Amino Collective
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $200K 0% 29
2025 $200K 0% 20
2024 $200K 0% 14
2023 $200K 4
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Rivia website traffic

Latest recorded traffic for Rivia is 4.7K monthly website visits, down 48.4% over the last three months. Rivia's team grew 45% over the past year.

Latest monthly visits4.7K 3-month web change-48.4% 1-year team growth+45%
Monthly website visits32 observations · Aug 2023–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Rivia compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Climedo HealthOur digital solutions (EDC, ePRO, eCRF and eSurvey) enable you to collect clinical data in a decentralized, automated and secure way. You'll benefit from faster implementation, improved data quality and better patient engagement Munich, Germany Operational 27 $6.8M $22M
InatoAI-powered patient recruitment Paris, France Operational
Science4Tech SolutionsUnleashing the power of data and AI for clinical trials Barcelona, Spain Operational
Lindus HealthAccelerates clinical trials for biotech and healthtech pioneers London, United Kingdom Operational
NorthWest E-HealthClinical trial platform, which enables more effective feasibility, economic modeling, recruitment, real-time safety monitoring, and data analytics Manchester, United Kingdom Operational
NovadiscoveryDe-risking technology provider specialized in in silico clinical trials supporting biotech and pharma companies Lyon, France Operational
BC PlatformsA global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice Zurich, Switzerland Operational
VerisianVerisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs) London, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Talent graph

Rivia's talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Rivia's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 3 investors entered at this stage
Speedinvest
Nina Capital
Amino Collective
Series A 2 investors entered at this stage

Global footprint

Where Rivia has talent and traffic

Workforce by country
5 countries with
team presence
🇨🇭 Switzerland78.3%
🇺🇸 United States8.7%
🇬🇧 United Kingdom4.3%
🇵🇹 Portugal4.3%
🇩🇪 Germany4.3%
5 countries shown

In the news

Latest news about Rivia

Recent press, funding announcements, and product moves mentioning Rivia — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Rivia

An AI-synthesized read of the highest-engagement posts about Rivia on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rivia’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.